
Gilead Sciences is preparing to lay off around a fifth of its salesforce in anticipation for the expiry of patents …
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals

